Posts in tag

Organon


Professor Andrew Oster, Consultant Rheumatologist at the Cabrini Medical Centre in Malvern, Victoria, explains the opportunities biosimilars bring, allowing patients to switch medications. Given the interchangeability of biosimilars, he emphasises …

Head of Pharmacy at Blooms The Chemist, Eric Chan emphasises the importance of collaborative care in cultivating a relationship of trust and transparency between a pharmacist and physician. He outlines …

Video 1: Michelle Leech: Bolstering patient confidence through collaborative care Professor Michelle Leech, Head of the Rheumatoid Arthritis Clinic at Monash Health, Victoria, explains the importance of bolstering patient confidence through …

Rheumatologist, Dr Gerald Tracey explains the opportunities biosimilars present for prescribing physicians, particularly given the government supported streamlined process. Gerald highlights the advantages of collaborative care between the prescriber and …

Trent Twomey, the National President of the Pharmacy Guild of Australia highlights the shifting power dynamic from physicians to patients in determining what medicines they are prescribed. Collaborative care is …

Professor Michelle Leech, Head of the Rheumatoid Arthritis Clinic at Monash Health, Victoria, explains the importance of bolstering patient confidence through collaborative care. Displaying this combined physician and pharmacist approach …

George Tambassis, Pharmacist, ex-National Guild President, and chair of the Australian Biosimilar Academy Advisory Board outlines the importance of pharmacist involvement in understanding biosimilars. Given the government supported Community Pharmacy …